The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry.
Cahana
Alex
A
Postoperative and Interventional Pain Program, Department of Anesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospital, 24 Rue Micheli-du-Crest, 1211 Geneva, 14, Geneva, Switzerland.
Mauron
Alexandre
A
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence / Q000592:standards*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D040541:Marketing / Q000941:ethics; D013450:Sulfones / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib